These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25087633)

  • 1. Synthesis of ¹³C-lidocaine as a probe of breath test for the evaluation of cytochrome P450 activity.
    Mitome H; Sugiyama E; Sato H; Akira K
    Chem Pharm Bull (Tokyo); 2014; 62(8):806-9. PubMed ID: 25087633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 13C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants: a pilot study.
    de Wildt SN; Berns MJ; van den Anker JN
    Ther Drug Monit; 2007 Apr; 29(2):225-30. PubMed ID: 17417078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test.
    Michael M; Cullinane C; Hatzimihalis A; O'Kane C; Milner A; Booth R; Schlicht S; Clarke SJ; Francis P
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):125-35. PubMed ID: 21626050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on sulfation of synthesized metabolites from the local anesthetics ropivacaine and lidocaine using human cloned sulfotransferases.
    Falany CN; Falany JL; Wang J; Hedström J; von Euler Chelpin H; Swedmark S
    Drug Metab Dispos; 1999 Sep; 27(9):1057-63. PubMed ID: 10460806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats.
    Sugiyama E; Kikuchi A; Inada M; Sato H
    J Pharm Sci; 2011 Sep; 100(9):3995-4005. PubMed ID: 21618542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of lidocaine desethyl metabolites.
    Walson PD
    Clin Pharmacol Ther; 1997 Nov; 62(5):579. PubMed ID: 9390117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preparation of lidocaine nanoemulsion and its transdermal absorption by rat skin ex vivo].
    Zhu XL; Li GF; Zeng K; Cheng ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):451-4. PubMed ID: 20335107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of cytochrome P450 3A4 and glutathione S-transferase A1-transfected human hepatoma cell line and functional analysis.
    Chang BX; You SL; Liu HL; Mao PY; Xin SJ
    Genet Mol Res; 2014 Apr; 13(3):6949-61. PubMed ID: 24782212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the absorption, distribution and metabolism of labelled prilocaine and lidocaine in some animal species.
    Akerman B; Aström A; Ross S; Telc A
    Acta Pharmacol Toxicol (Copenh); 1966; 24(4):389-403. PubMed ID: 6013121
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lidocaine: local anaesthetic with systemic toxicity].
    Gremmels H
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):529; author reply 529. PubMed ID: 18389892
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of lidocaine-loaded PLGA microparticles by flow focusing. Effects on drug loading and release properties.
    Holgado MA; Arias JL; Cózar MJ; Alvarez-Fuentes J; Gañán-Calvo AM; Fernández-Arévalo M
    Int J Pharm; 2008 Jun; 358(1-2):27-35. PubMed ID: 18372128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
    Zhu X; Li F; Peng X; Zeng K
    Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lidocaine and MEGX concentrations after pharyngeal anesthesia for gastroscopy.
    Gandolfi L
    Gastrointest Endosc; 1995 Sep; 42(3):282-3. PubMed ID: 7498708
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.
    Cakaloglu Y; Tredger JM; Devlin J; Williams R
    Hepatology; 1994 Aug; 20(2):309-16. PubMed ID: 7519161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New local anesthetics.
    Shah J; Votta-Velis EG; Borgeat A
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):179-185. PubMed ID: 30322458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desirable pharmacokinetic properties of (13)C-uracil as a breath test probe of gastric emptying in comparison with (13)C-acetate and (13)C-octanoate in rats.
    Sugiyama E; Inada M; Kunizaki J; Tobita K; Yoshida T; Kashimoto M; Hirao Y; Sato H
    Scand J Gastroenterol; 2009; 44(9):1067-75. PubMed ID: 19585373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of lidocaine and its active metabolite monoethylglycinexylidide after a single intravenous administration in chickens (Gallus domesticus) anesthetized with isoflurane.
    Da Cunha AF; Messenger KM; Stout RW; Barker SA; Nevarez JG; Queiroz-Williams P; Tully TN
    J Vet Pharmacol Ther; 2012 Dec; 35(6):604-7. PubMed ID: 22212047
    [No Abstract]   [Full Text] [Related]  

  • 18. Design and Development of Lidocaine Microemulsions for Transdermal Delivery.
    Wang Y; Wang X; Wang X; Song Y; Wang X; Hao J
    AAPS PharmSciTech; 2019 Jan; 20(2):63. PubMed ID: 30627930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration enhancers and other factors governing percutaneous local anaesthesia with lidocaine.
    Akerman B; Haegerstam G; Pring BG; Sandberg R
    Acta Pharmacol Toxicol (Copenh); 1979 Jul; 45(1):58-65. PubMed ID: 474160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.
    Isohanni MH; Neuvonen PJ; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):168-72. PubMed ID: 16918719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.